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OASIS modulates hypoxia 
pathway activity to regulate  
bone angiogenesis
Min Cui1, Soshi Kanemoto1, Xiang Cui1, Masayuki Kaneko1, Rie Asada1, Koji Matsuhisa1, 
Keiji Tanimoto2, Yuki Yoshimoto3, Chisa Shukunami3 & Kazunori Imaizumi1
OASIS/CREB3L1, an endoplasmic reticulum (ER)-resident transcription factor, plays important roles in 
osteoblast differentiation. In this study, we identified new crosstalk between OASIS and the hypoxia 
signaling pathway, which regulates vascularization during bone development. RT-PCR and real-time 
PCR analyses revealed significant decreases in the expression levels of hypoxia-inducible factor-1α 
(HIF-1α) target genes such as vascular endothelial growth factor A (VEGFA) in OASIS-deficient 
(Oasis−/−) mouse embryonic fibroblasts. In coimmunoprecipitation experiments, the N-terminal 
fragment of OASIS (OASIS-N; activated form of OASIS) bound to HIF-1α through the bZIP domain. 
Luciferase assays showed that OASIS-N promoted the transcription activities of a reporter gene via 
a hypoxia-response element (HRE). Furthermore, the expression levels of an angiogenic factor Vegfa 
was decreased in Oasis−/− osteoblasts. Immunostaining and metatarsal angiogenesis assay showed 
retarded vascularization in bone tissue of Oasis−/− mice. These results suggest that OASIS affects 
the expression of HIF-1α target genes through the protein interaction with HIF-1α, and that OASIS-
HIF-1α complexes may play essential roles in angiogenesis during bone development.
The endoplasmic reticulum (ER) is a cellular organelle that plays important roles in protein synthesis, 
protein folding, and post-translational modifications of secreted proteins1,2. Environmental and genetic 
factors, such as ischemia, glucose deprivation, or mutant protein expression, cause the accumulation of 
misfolded and/or unfolded proteins in the ER lumen. This condition is called ER stress3–5. Cells cope 
with ER stress by activating diverse signals from the ER to the cytoplasm or nucleus, which is termed 
the unfolded protein response (UPR)6–8. The signaling cascades during the UPR are mainly mediated by 
three major ER stress transducers, PKR-like endoplasmic reticulum kinase (PERK)9, inositol-requiring 
enzyme 1 (IRE1)10, and activating transcription factor 6 (ATF6)11,12. These transducers sense the accu-
mulation of unfolded proteins in the ER lumen and transmit signals for attenuation of ER stress.
Recently, novel types of ER stress transducers have been identified, which are referred to as the OASIS 
family13–15. These proteins are structurally similar to ATF6, possess a basic leucine zipper (bZIP) domain 
and a transmembrane domain. The bZIP domain contains a basic motif region that mediates sequence 
specific DNA binding properties, and the leucine zipper that is required to dimerize two DNA binding 
regions. The OASIS family consists of five members, namely old astrocyte specifically induced substance 
(OASIS)/CREB3L116, BBF2 human homolog on chromosome 7 (BBF2H7)/CREB3L217, Luman/LZIP/
cyclic AMP-response element-binding protein 3 (CREB3)18, cyclic AMP-response element-binding pro-
tein H (CREBH)/CREB3L319, and androgen-induced bZIP (AIbZIP)/CREB4/Tisp40/CREB3L420. All five 
members are basically localized to the ER membrane, become transported to the Golgi apparatus in 
response to various stimuli such as ER stress, and are then processed by Site-1 and Site-2 proteases at 
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their transmembrane domains21. The cleaved N-terminal fragments of the OASIS family members move 
into the nucleus, and act as transcription factors. The unique feature of the OASIS family members is 
their cell type- or tissue-specific expression patterns. For example, OASIS is preferentially expressed in 
osteoblasts and astrocytes13,21, BBF2H7 in chondrocytes22, CREBH in liver cells23,24, and AIbZIP in the 
testis and prostate25,26. These observations suggest that the functions of the individual members may be 
involved in regulation of the UPR in specific organs and tissues.
OASIS is constitutively degraded under normal conditions, but ER stress leads to inhibition of ubiquit-
ination and proteasome-mediated degradation of OASIS by HRD1, which is an ER-resident E3 ubiquitin 
ligase. Both full-length and cleaved OASIS are significantly stabilized by ER stress, with cleaved OASIS 
enhancing transcriptional activation of its target genes27. Moreover, we previously showed that OASIS 
is highly expressed in osteoblasts and regulates the transcription of type 1 collagen21. Furthermore, we 
demonstrated that deficiency of OASIS is associated with an osteopenic phenotype21, indicating that 
OASIS plays an essential role in osteogenesis. Recently, OASIS was identified as one of the causative genes 
for osteogenesis imperfecta in humans28. In addition, OASIS is involved in the differentiation of various 
cells such as goblet cells and astrocytes as well as those in bone tissues15,29–31. These findings demonstrate 
that OASIS has pivotal roles in the differentiation of various tissues.
Hypoxia is a condition in which organs or cells are deprived of an adequate oxygen supply. When 
cells are exposed to hypoxic conditions, adaptive signal transduction pathways are activated, resulting 
in the secretion of various factors that contribute to angiogenesis32,33. Recent evidence from basic and 
clinical research studies has indicated that hypoxia is a strong activator of the UPR34,35, and that the UPR 
regulates the expressions of genes that are known to increase hypoxia tolerance and survival in cells36,37. 
However, the molecular mechanisms and physiological functions of the UPR during hypoxia are still 
poorly understood.
Hypoxia-inducible factors (HIFs) are important regulators of cellular homeostatic responses to 
hypoxia38. HIFs contain a Per-ARNT-Sim (PAS) domain essential for interactions with their cofactor pro-
teins, and a basic helix-loop-helix (bHLH) domain required for DNA binding to the hypoxia-response 
element (HRE) in the promoter region of their target genes39–43. HIF-1α , one of the HIF subtype pro-
teins, plays key roles in embryonic vascularization, tumor angiogenesis, and pathophysiological ischemic 
diseases44,45. The stability of HIF-1α is regulated by hydroxylation of proline residues in its polypeptide 
sequence. In normoxia, hydroxylation at proline 402 and proline 564 in the HIF-1α protein creates a 
binding site for von Hippel-Lindau (VHL) protein, an E3 ubiquitin protein ligase46,47. VHL promotes the 
ubiquitination of HIF-1α and leads to proteasomal degradation of a HIF-1α subunit48. Under hypoxia, 
the proline hydroxylation in HIF-1α is impaired and ubiquitination of HIF-1α is attenuated, leading to 
stabilization of HIF-1α . HIF-1α dimerizes with HIF-1β through its bHLH-PAS domain49, and binds to 
the promoter region of target genes such as vascular endothelial growth factor A (VEGFA) to facilitate 
their expression40.
VEGFA is expressed in chondrocytes and osteoblasts as an important regulator of angiogenesis during 
endochondral ossification43,50–52. Functional deprivation of VEGFA in developing cartilage causes inhi-
bition of blood vessel invasion into the hypertrophic zone, resulting in impairment of trabecular bone 
formation and expansion of the hypertrophic zone53. Recently, it was reported that ER stress potentiated 
HIF-1α activity to promote transcription of VEGFA35.
In the present study, we found that OASIS is upregulated in a time-dependent manner during 
hypoxia, and that OASIS binds to HIF-1α through its bZIP domain and promotes the transcription of 
hypoxia-inducible genes including VEGFA under hypoxic conditions. Furthermore, OASIS deficiency 
causes impairment of vessel formation in bone tissue.
Results
OASIS regulates the expression of HIF-1α target genes. OASIS, a type 2 transmembrane bZIP 
transcription factor (Fig.  1a), plays important roles in the maturation of osteoblasts and bone forma-
tion21. However, the detailed mechanisms underlying the regulation of osteogenesis by OASIS are not 
fully understood. Therefore, we carried out a profiling analysis of gene expressions in osteoblasts derived 
from wild-type (WT) and OASIS-deficient (Oasis−/−) mice21 (database: http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc= GSE18062). Intriguingly, we found that the expressions of the vast majority of 
HIF-1α target genes were reduced in Oasis−/− cells (Supplementary Table 2). To confirm the results of 
the gene expression profiling, we performed RT-PCR and real-time PCR analyses using WT and Oasis−/− 
mouse embryonic fibroblasts (MEFs) and primary osteoblasts under hypoxic conditions (0.2% oxygen). 
The expression levels of HIF-1α target genes, such as Adm, Ca9 and Vegfa were significantly reduced 
in Oasis−/− cells compared with WT cells (Fig.  1b,c, Supplementary Figure S1a,b). Next, we examined 
whether OASIS affects the expression level of HIF-1α . Western blot analyses of cell lysates from WT and 
Oasis−/− MEFs cultured under normoxia or hypoxia showed no significant difference in the protein levels 
of HIF-1α between WT and Oasis−/− MEFs (Fig.  1e,f). Moreover, we checked the expression levels of 
HIF-1α in the primary osteoblasts and osteoblastic cell line MC3T3-E1 in which OASIS was knocked 
down by siRNA transfection. Similar to the case with MEFs, no difference in the HIF-1α protein levels 
was observed between OASIS-knockdown MC3T3-E1 cells and control cells or Oasis−/− primary osteo-
blast and WT osteoblasts (Fig. 1d,g,h). These data suggest that OASIS deficiency causes downregulation 
of HIF1α target gene expressions without any impact on HIF-1α expression.
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Figure 1. OASIS regulates the expression of HIF-1α target genes. (a) Schematic representation of human 
OASIS protein. (b) Real-time PCR analyses of WT and Oasis−/− Primary osteoblasts. Cells were exposed to 
hypoxia (0.2% oxygen) for the indicated time periods (mean ± s.d., n = 3; *P < 0.05, t-test). Note that the 
expression levels of the HIF-1α target genes are impaired in Oasis−/− cells. (c) Real-time PCR analyses of 
WT and Oasis−/− mouse embryonic fibroblasts (MEFs). Cells were exposed to hypoxia (0.2% oxygen) for 
the indicated time periods (mean ± s.d., n = 3; *P < 0.05, t-test). (d) Western blot analyses for OASIS and 
HIF-1α . Primary osteoblasts cells were exposed to hypoxia for 6 h. Cell lysates were subjected to western 
blotting analyses using anti-OASIS and anti-HIF-1α antibodies. Asterisk, nonspecific bands. (e,f) Western 
blot analyses for HIF-1α . WT and Oasis−/− MEFs were exposed to hypoxia (0.2% oxygen) for the indicated 
time periods. A quantitative chart is shown in panel f (mean ± s.d., n = 3; NS, not significant P > 0.05, 
t-test). (g,h) Western blot analyses for OASIS and HIF-1α . MC3T3-E1 cells were transfected with scramble 
siRNA (Sc) or OASIS-specific siRNA (Si) and exposed to hypoxia for 6 h. Cell lysates were subjected 
to western blot analyses using anti-OASIS and anti-HIF-1α antibodies. Asterisk, nonspecific bands; 
arrow, specific bands for OASIS. A quantitative chart is shown in panel h (mean ± s.d., n = 3; *P < 0.05, 
NS, not significant = P > 0.05, t-test). Full-length blots are presented in the supplementary information 
(supplementary Figure S5).
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OASIS is activated by hypoxia and interacts with HIF1α. We investigated the subcellular locali-
zations of OASIS and HIF-1α . HEK293T cells were cotransfected with expression plasmids for the OASIS 
N-terminus (OASIS-N; active form) and a stabilized form of HIF-1α that has mutations in hydroxylation 
sites and is constitutively activated (HIF1α P-A; P402A/P564A)54,55. Immunofluorescence staining with 
anti-OASIS and anti-HIF-1α antibodies showed that OASIS-N and HIF-1α P-A were both localized to 
the nucleus (Fig.  2a). To further understand the physiological distribution, we examined the localiza-
tions of endogenous OASIS and HIF-1α in MC3T3-E1 cells under normoxia or hypoxia. As previously 
reported56, HIF-1α was detected in the nucleus of MC3T3-E1 cells under both normoxia and hypoxia 
(Fig. 2b, left panels). On the other hand, although OASIS was diffusively localized in the cytoplasm and 
nucleus under normoxia, the signals for OASIS were strongly detected in the nucleus under hypoxia, 
and overlapped with those of HIF-1α (Fig. 2b, middle panels and the intensity images, Supplementary 
Figure S2a–c). These observations suggest that OASIS might be cleaved and activated in the hypoxic 
conditions, and may interact with HIF-1α in the nucleus. To confirm that OASIS is activated by hypoxia, 
we conducted western blotting analyses of OASIS in MC3T3-E1 cells exposed to hypoxia for different 
time periods. As expected, the cleaved OASIS N-terminal fragment gradually increased within 12–36 h 
after hypoxic exposure (Fig. 2c,d, Supplementary Figure S2d). Additionally, overexpression of OASIS in 
HEK293T showed that the increased amount of OASIS leads to an increase in the relative expression of 
nuclear HIF-1α (Supplementary Figure S3a,b). Note that the overexpression of OASIS-N might influence 
the localization and the consumption rate of HIF-1α .
Next, we performed coimmunoprecipitation (Co-IP) experiments to examine the physical interac-
tion between OASIS-N and HIF-1α . We found that HIF-1α was coprecipitated with OASIS-N, and 
conversely, that OASIS-N was coprecipitated with HIF-1α (Fig.  2e, Supplementary Figure S2e). These 
results indicate that OASIS-N and HIF-1α physically interact with each other. To further verify the 
direct interaction between HIF-1α and OASIS-N, a glutathione S-transferase (GST) pulldown assay was 
performed. The in vitro GST pulldown assay confirmed a direct interaction between GST-OASIS-N and 
HIF-1α (Fig. 2f). These data indicate that OASIS becomes activated under hypoxia and has the potential 
to bind to HIF-1α and affect the transcription of HIF-1α target genes.
OASIS promotes the transcription of HIF-1α target genes through an HRE. It is known that 
HIF-1α promotes the transcription of its target genes through an HRE56. To assess whether OASIS-N 
affects the transcription of HIF-1α target genes through an HRE, we generated a pGL3-5 × HRE reporter 
plasmid (HRE sequence: 5′ -TCGAGCCACAGTGCATACGTGGGCTCCAACAGGTCCTCTTG-3′ ) 
(Fig.  3a) as previously reported57, and performed luciferase assays. Compared with mock-transfected 
cells, the reporter activities of cells transfected with OASIS-N or HIF-1α were significantly increased 
(Fig.  3b). When cells were cotransfected with both OASIS-N and HIF-1α , the reporter activities were 
enhanced in an additive manner (Fig. 3b). Furthermore, we examined the reporter activities in response 
to hypoxia or cobalt dichloride (CoCl2), which mimics the hypoxic conditions and induces stabiliza-
tion of HIF-1α . In a similar manner to the above-described findings, hypoxia and CoCl2 increased 
the reporter activities in control cells (Fig.  3c, Supplementary Figure S2f). Furthermore, expression 
of OASIS-N in hypoxia or CoCl2 treated cells reinforced the reporter activities in an additive manner 
(Fig.  3c, Supplementary Figure S2f). To investigate the effect of endogenous OASIS on the HRE, we 
performed luciferase assays using WT and Oasis−/− MEFs. Upon introduction of the pGL3-Basic control 
reporter plasmid lacking a promoter region, the reporter activities in WT and Oasis−/− MEFs showed no 
difference, even under hypoxia (Fig. 3d, top). In contrast, the reporter activities in WT MEFs transfected 
with the pGL3-5 × HRE reporter plasmid were dramatically increased in response to hypoxia (Fig. 3d, 
bottom). However, the luciferase activities under hypoxia were remarkably suppressed in Oasis−/− MEFs 
(Fig. 3d, bottom). Thus, OASIS is likely to regulate the expression of HIF-1α target genes through the 
HRE in a coordinated manner with HIF-1α .
The bZIP domain of OASIS binds to the bHLH domain of HIFs. To examine whether the bZIP 
region of OASIS is important for the interaction between OASIS and HIF-1α , we constructed an expres-
sion plasmid for bZIP domain-deleted OASIS with a Flag-tag at the N-terminus (Flag-OASIS-N Δ bZIP) 
(Fig. 4a), and performed Co-IP experiments. Co-IP and western blot analyses showed that HIF-1α was 
coprecipitated with Flag-OASIS-N (Fig. 4b, top), but not with Flag-OASIS-N Δ bZIP (Fig. 4b, bottom). 
Moreover, luciferase assays with the Flag-OASIS-N Δ bZIP expression plasmid and pGL3-5 × HRE 
reporter plasmid revealed that Flag-OASIS-N Δ bZIP abolished induction of the promoter activity 
through the HRE (Fig.  4c). When the Flag-OASIS-N Δ bZIP and HIF-1α expression plasmids were 
cotransfected, the reporter activities were not enhanced in an additive manner compared with introduc-
tion of HIF-1α only (Fig.  4c). To further examine the binding region of OASIS in HIF-1α , we gener-
ated four kinds of Flag-tagged HIF1α deletion constructs; HIF-1α Δ bHLH (109-826aa), HIF-1α 109 
(1-109aa), HIF-1α 333 (1-333aa) and HIF-1α 530 (1-530aa) and a construct of HIF-2α , which is an 
important HIF-1α homologous protein engaged in the hypoxia pathway (Fig.  4d). Co-IP experiments 
using a Myc-tagged OASIS-N expression plasmid and the HIF-1α mutant series or HIF-2α construct 
showed that only HIF-1α Δ bHLH was not coprecipitated with OASIS-N, while the remaining HIF 
constructs were all coprecipitated with OASIS-N (Fig.  4e). These results indicate that the OASIS bZIP 
domain interacts with the bHLH domain of HIF-1α and HIF-2α .
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Figure 2. OASIS is activated by hypoxia and interacts with HIF-1α. (a) Immunofluorescence staining 
for HIF-1α and OASIS. HEK293T cells were cotransfected with HIF-1α P402A/P564A (HIF-1α P-A; 
constitutively activated stabilized form) and OASIS N-terminus (OASIS-N) expression plasmids. Both 
HIF-1α P-A (green) and OASIS-N (red) are detected in the nucleus. (b) Immunofluorescence analyses of 
endogenous HIF-1α (green) and OASIS (red) in MC3T3-E1 cells under normoxia or hypoxia (0.2% oxygen, 
24 h). Intensity images showed increasing nuclear intensity of OASIS in the MC3T3-E1 under hypoxia. (c,d) 
Western blot analyses for HIF-1α and OASIS. MC3T3-E1 cells were exposed to hypoxia (0.2% oxygen) for 
the indicated time periods. Asterisk, nonspecific bands; arrow, specific bands for OASIS. A quantitative 
chart is shown in panel d (mean ± s.d., n = 3; *P < 0.05; t-test). (e) Co-IP followed by western blot analyses 
of HIF-1α and OASIS. HEK293T cells were transfected with Flag-tagged OASIS-N and exposed to hypoxia. 
Cell lysates were subjected to Co-IP assays with anti-Flag or anti-HIF-1α antibodies. The IP samples were 
subjected to western blotting with anti-HIF-1α and anti-OASIS antibodies. (f) GST pulldown assays to 
examine the protein interaction of OASIS and HIF-1α . Recombinant GST-OASIS-N or GST proteins were 
produced in E. coli BL21 cells. Recombinant proteins were incubated with cell lysates from hypoxia-exposed 
MC3T3-E1 cells. Pulldown was carried out using glutathione-Sepharose beads and western blotting with 
anti-HIF-1α antibodies was performed. Coomassie Brilliant Blue (CBB) staining confirmed the existence 
of GST-OASIS-N in pulldown samples. Full-length blots are presented in the supplementary information 
(supplementary Figure S6).
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OASIS plays a crucial role in vascularization during bone development. Previously, we observed 
systemic osteopenia in Oasis−/− mice that was not limited to the femurs or tibias21. Reductions in bone 
mass in the skeletal system cause marked fragility of bone, and bone fractures are often observed in the 
vertebrae and long bones of Oasis−/− mice. Van Gieson staining of undecalcified frozen tibial sections 
from juvenile mice revealed the osteopenic phenotype of Oasis−/− mice (Fig. 5a). The collagen density 
in cortical bone was decreased in Oasis−/− mice (Fig. 5b, top), and the thickness of trabecular bone was 
markedly reduced (Fig. 5b, bottom).
Figure 3. OASIS enhances the promoter activity of the HRE. (a) Schematic representation of the 
5 × HRE reporter construct and the inserted sequence of the HRE. (b) Luciferase reporter analyses of 
the 5 × HRE promoter. HEK293T cells were cotransfected with the pGL3-5 × HRE reporter plasmid 
and the OASIS-N and/or HIF-1α expression plasmids. At 24 h after transfection, the luciferase activities 
were measured (mean ± s.d., n = 6; **P < 0.01, ***P < 0.001, t-test). Cell lysates were subjected to western 
blotting with anti-HIF-1α or anti-OASIS antibodies to check the protein levels of overexpressed HIF-1α 
or OASIS. (c) Luciferase reporter analyses for the 5 × HRE promoter in response hypoxia. HEK293T cells 
were transfected with the pGL3-5 × HRE reporter plasmid and the OASIS-N or Mock plasmids. At 12 h 
after transfection, cells were exposed to the normoxia or hypoxia for 12 h (mean ± s.d., n = 3; *P < 0.05, 
**P < 0.01, ***P < 0.001, t-test). (d) Luciferase reporter analyses of the 5 × HRE promoter under hypoxia. 
WT or Oasis−/− MEFs were transfected with pGL3-Basic or pGL3-5 × HRE reporter plasmids and exposed 
to normoxia or hypoxia for 24 h (mean ± s.d., n = 3; *P < 0.05, **P < 0.01, t-test). Note that the reporter 
activities of Oasis−/− cells under hypoxia are significantly suppressed compared with those in WT cells. Full-
length blots are presented in the supplementary information (supplementary Figure S7).
www.nature.com/scientificreports/
7Scientific RepoRts | 5:16455 | DOI: 10.1038/srep16455
A recent study showed that deprivation of VEGFA inhibits blood vessel formation in the marrow 
cavity53, resulting in reduced trabecular bone and reflecting a similar phenotype to that of Oasis−/− mice. 
VEGFA is an important target of HIF1α involved in angiogenesis, and our present findings indicating 
that OASIS has an irreplaceable function in the HIF-1α pathway suggest that OASIS regulates bone angi-
ogenesis by mediating the HIF-1α -VEGFA signaling cascade. To gain further insight into the defective 
angiogenesis in Oasis−/− mice, we examined the VEGFA gene expression in primary cultured osteoblasts 
Figure 4. bZIP domain of OASIS binds to the bHLH domain of HIFs. (a) Schematic representation of the 
Flag-OASIS-N and Flag-OASIS-N Δ bZIP constructs. (b) Co-IP and western blot analyses. HEK293T cells 
were transfected with HIF-1α P-A and FLAG-OASIS-N or FLAG-OASIS-N Δ bZIP expression plasmids. 
Cell lysates were subjected to Co-IP with anti-Flag antibodies, and the IP samples were subjected to western 
blotting with anti-HIF-1α and anti-OASIS antibodies. (c) Luciferase reporter analyses of the 5 × HRE 
promoter. HEK293T cells were cotransfected with a pGL3-5 × HRE reporter plasmid and FLAG-OASIS-N 
Δ bZIP and/or HIF-1α expression plasmids (means ± s.d., n = 6; ***P < 0.001, t-test). (d) Schematic 
representations of the Flag-tagged HIF-1α deletion mutant and Flag-tagged HIF-2α expression plasmids. (e) 
Co-IP and western blot analyses using HIF-1α mutants and HIF-2α . HEK293T cells were transfected with 
the Myc-tagged OASIS-N expression plasmid together with a series of HIF-1α mutant or HIF-2α expression 
plasmids. Co-IP of cell lysates was performed with anti-Flag antibodies, and the IP samples were subjected 
to western blotting analyses with anti-Myc and anti-Flag antibodies (*IgG-H fragments, **IgG-L fragments). 
Full-length blots are presented in the supplementary information (supplementary Figure S8).
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Figure 5. OASIS plays a crucial role in vascularization during bone development. (a) Van Gieson 
staining of undecalcified frozen tibial sections from WT and Oasis−/− mice (28 days-old). Van Gieson 
staining only detects the collagen matrix in bone tissues. Note the dramatic decrease in the collagen fibril 
content in Oasis−/− mice compared with that in WT mice. Scale bar, 500 μ m. (b) Higher magnification 
images of cortical bone and trabecular bones in the boxes shown in panel a. Arrowheads indicate 
trabecular bones. Scale bar, 200 μ m. (c,d) Real-time PCR analyses of OASIS and VEGFA expressions in 
WT and Oasis−/− primary cultured osteoblasts (C) and tibia tissues (D). The expression of Vegfa mRNA 
is significantly decreased in Oasis−/− cells and bone tissues (mean ± s.d., n = 3; *P < 0.05, ***P < 0.001, 
t-test). (e–g) Immunofluorescence staining with anti-CD31 antibody in undecalcified frozen tibial sections 
from WT and Oasis−/− juvenile mice (28 days-old). Note that retarded vascularization is observed in the 
Oasis−/− tibia. Quantitation of the vessel areas (f) and the vessel lengths (g) are indicated in panel f and g 
(mean ± s.d., n = 5; *P < 0.05, t-test). Scale bar, 200 μ m. (h,i) Absence of OASIS decreases angiogenesis in 
metatarsal explants. Metatarsal explants stained for endothelial cells (red, CD31); P0.5 mouse metatarsals 
derived from WT and Oasis−/− mice were cultured for 15 days before fixation. Green color showed the 
pattern of mosue metatarsal. Quantitation of the vessel areas are indicated in panel h (mean ± s.d., n = 6; 
**P < 0.01, t-test).
www.nature.com/scientificreports/
9Scientific RepoRts | 5:16455 | DOI: 10.1038/srep16455
(Fig. 5c) and bone tissues (Fig. 5d). Real-time PCR analyses showed that the expression levels of VEGFA 
were substantially suppressed in Oasis−/− osteoblasts and Oasis−/− bone tissues (Fig. 5c,d).
To examine the organization of blood vessels in bone, we carried out immunofluorescence staining 
using an antibody against CD31, also known as platelet endothelial cell adhesion molecule (PECAM), 
a specific marker for endothelial cells58, on undecalcified frozen tibial sections. In Oasis−/− mice, the 
CD31-positive vascular network development was significantly reduced compared with that in WT mice 
(Fig.  5e, Supplementary Figure S4a-f). The vessel quantity were apparently decreased in Oasis−/− mice 
compared with WT mice (Fig. 5f,g). To determine the effect of OASIS on bone angiogenesis in a more 
physiological model, we performed an ex vivo angiogenesis assay using P0.5 mouse metatarsals from 
WT and Oasis−/− mice. This assay showed that angiogenesis in fetal mouse metatarsals was remarkably 
decreased in Oasis−/− mice compared with WT mice (Fig. 5h,i).
Discussion
The present study has significantly extended our understanding of the physiological roles of OASIS, an 
ER stress transducer, in the hypoxia stress response. The following evidence demonstrates that OASIS 
regulates the expression of HIF-1α target genes by interacting with HIF-1α under hypoxia: 1) the expres-
sion of HIF-1α target genes was significantly suppressed in Oasis−/− cells (Fig. 1b,c); 2) OASIS was acti-
vated in response to hypoxia (Fig. 2c,d); 3) OASIS interacted with HIF-1α and HIF-2α directly (Figs 2e,f 
and 4e); 4) OASIS N-terminus might be involved in the nuclear localization of HIF-1α (Supplementary 
Figure 3a,b); 5) OASIS strongly promoted gene transcription activities through the HRE (Fig. 3b); and 
6) the absence of OASIS impaired the vascular network development mediated by the HIF-1α -VEGF 
signaling cascade in bone tissues (Fig. 5e,h). We suppose the following mechanism for the activation and 
physiological roles of OASIS under hypoxia. OASIS is transported from the ER to the Golgi apparatus, 
and undergoes processing by S1P and S2P proteases. The activated OASIS N-terminus then interacts with 
HIF1α to directly promote the expression of target genes such as Vegfa through the HRE (Fig. 6). It is 
known that OASIS is activated by ER stress59. On the other hand, several lines of evidence have shown 
that hypoxic conditions can induce ER stress in several cell types60. Therefore, the mechanism for OASIS 
activation during hypoxia might be caused by hypoxia-induced ER stress. Taken together, the present 
findings show that OASIS plays essential roles in bone development, not only through the production of 
bone matrix by regulating Col1 expression directly21, but also through the promotion of bone angiogen-
esis by interacting with the transcription factor HIF-1α .
We previously reported that the bZIP transcription factor OASIS regulates the expression of VEGFA 
through binding to a CRE-like core sequence (ACGT) in the VEGFA promoter region61. It is also known 
that HIF-1α regulates VEGFA expression through the HRE62. The HRE sequence (G/ACGTG) is sim-
ilar to the binding sequence of OASIS (i.e. ACGT). Indeed, we demonstrated that the activated OASIS 
N-terminus interacts with HIF-1α and enhances the promoter activity through the HRE sequence 
(Figs 2e,f and 3b,c). A recent study showed that one of the bZIP family proteins, XBP1, can interact with 
HIF-1α in particular cell types54. It is known that the bZIP domains in the family members resemble one 
another structurally, and could potentially bind to each other63. These findings raise the further possi-
bility of interactions between bZIP family proteins and bHLH family proteins to synergistically control 
their target gene expressions in several pathophysiological conditions. HIF-1α requires heterodimeriza-
tion with aryl hydrocarbon receptor nuclear translocator (Arnt/HIF-1β ) in the nucleus to promote its 
target gene transcriptions64. Although we demonstrated direct interactions of OASIS with HIF-1α and 
HIF-2α , the interaction between OASIS and HIF-1β is still unknown, and the relevance of interactions 
Figure 6. Model for the mechanisms of bone vascularization by OASIS in osteoblasts. Under hypoxic 
conditions, OASIS is transported from ER to the Golgi apparatus, and undergoes processing by S1P and 
S2P proteases. The cleaved OASIS N-terminus and stabilized HIF-1α form a heterodimer in nucleus and 
synergistically promote the transcriptional activation of HIF-1α target genes through the hypoxia-response 
element. VHL: von Hippel-Lindau; RIP: regulated intramembrane proteolysis; ER: endoplasmic reticulum; 
OH: hydroxylation; HRE: hypoxia-response element. (Figure was drawn by Min Cui).
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between HIFs and other kinds of OASIS family proteins has not yet been studied. Further investigations 
are required to elucidate the functions and mechanisms of the interactions between bZIP proteins and 
HIFs under physiological and pathological conditions in cells.
A previous report suggested that HIF-1α promotes angiogenesis and osteogenesis by elevating VEGF 
levels in osteoblasts in bone development65. During bone development, osteoblasts are exposed to mild 
hypoxic conditions, followed by attenuated hydroxylation of HIF-1α by VHL, resulting in elevated 
VEGFA expression66. VEGFA induces migration of endothelial cells to the oxygen-deficient zone to pro-
vide oxygen and nutrients for osteoblasts and chondrocytes and help their maturation and prolifera-
tion50,51. A novel finding regarding OASIS function in the present study was the involvement of OASIS 
in angiogenesis in bone tissue mediated by the HIF-1α pathway. OASIS deficiency led to imperfect vas-
cularization during bone development. Poorly produced blood vessels cannot provide sufficient nutrition 
to osteoblasts to develop trabecular bones, resulting in the formation of a vulnerable skeletal system. 
OASIS also regulates the expression of type I collagen, one of the bone matrix proteins21. Therefore, 
OASIS might engage in different phenomena during bone development by interacting with different 
binding partners.
In summary, we have shown that OASIS modulates the HIF-1α signaling pathway to contribute to 
bone vascularization. Our findings indicate that OASIS-HIF-1α complexes might improve angiogenesis 
during bone formation, wound healing, and granulated tissue formation. Furthermore, OASIS-HIF com-
plexes may provide better solutions in therapies for angiodysplasia in osteogenesis imperfecta.
Materials and Methods
Cell culture and reagents. MEF and HEK293T cells were grown in Dulbecco’s modified Eagle’s 
medium (Gibco, USA) containing 10% fetal calf serum (Sigma, USA). MC3T3-E1 (mouse osteoblast) 
cells were maintained in α -modified eagle medium (Gibco) containing 10% FCS. We used 1 μ M MG132 
(WAKO, Japan), a proteasome inhibitor, to inhibit protein degradation, and used 150 mM cobalt dichlo-
ride (WAKO) to mimic hypoxia.
RT-PCR and Real-time PCR. Total RNA was extracted from cells using ISOGEN (WAKO) according 
to the manufacturer’s protocol. First-strand cDNA was synthesized in a 20 μ l of reaction volume using a 
random primer (TAKARA, Japan) and 1 μ l reverse transcription enzyme M-MLV-RT (Invitrogen, USA). 
PCR was performed using each specific primer set in a total volume of 20 μ l containing 10 pmol of each 
primer, 4 μ mol dNTPs, 1 unit of Paq5000 DNA polymerase (Agilent, USA), and 1 × PCR buffer. Primer 
sequences are summarized in supplemental Table S1. The PCR products were resolved by electropho-
resis on a 4.8% acrylamide gel. For the real-time PCR analyses, SYBR FAST qPCR Master Mix (Kapa 
Biosystems, USA) was used, and PCR products were measured by LightCycler 480 II (Roche, Swiss).
Antibodies, Western blotting. Mouse monoclonal anti-OASIS antibodies were generated as 
described previously21. For western blotting and immunofluorescence, the following antibodies were 
used: anti-β -actin (Sigma; 1:3000), anti- HIF-1α (Novus, USA; 1:3000), anti-Flag M2 (Sigma; 1:2000), 
anti-Myc (MBL, USA; 1:3000), anti-CD31 (BD, USA; 1:1000). For western blot analyses, proteins were 
extracted from cells using cell extraction buffer containing 20 mM Tris-HCl (pH 7.5), 500 mM NaCl, 
10 mM MgCl2, 2 mM EDTA, 10% glycerol, 1% Triton X-100, 2.5 mM β -glycerophosphate, 1 mM NaF, 
1 mM DTT, and 1 mM complete protease inhibitors (WAKO) at 4 °C. After centrifugation, soluble protein 
in the lysates were quantified. Samples were loaded onto 8–12% sodium dodecyl sulfate-polyacrylamide 
gels. Protein-equivalent samples were subjected to western blotting.
Cytosol/Nuclear extraction. Cells were harvested by cell-scraper from 6 well plate, and cytosol pro-
teins were extracted using 100 μ l of cytosol lysis buffer1 (10 mM Hepes (pH 7.9), 10 mM KCl, 0.1 mM 
EDTA, 0.2% NP-40, 1 mM DTT, and complete protease inhibitors (WAKO)) at 4 °C for 15 min. Then 
6.25 μ l of 10% NP-40 was added (vortex for 15 seconds at maximum speed). Cell lysates were centri-
fuged at 4 °C, 13000 rpm for 10 seconds, then the supernatant were harvested as cytosol fraction. Pellets 
were washed with 500 μ l of cytosol lysis buffer1 for 5 times, then nuclear proteins were extracted using 
50 μ l nuclear lysis buffer2 (20 mM Hepes (pH 7.9), 420 mM NaCl, 0.1 mM EDTA, 1.5 mM MgCl2, 25% 
Glycerol, 1 mM DTT, and 1 mM complete protease inhibitors (WAKO)) at 4 °C for 30 min. Lysates were 
centrifuged at 4 °C, 15000 rpm for 15 min, the supernatant was harvested as the nuclear fraction.
Histological staining and immunofluorescence. Anesthetized mice were perfused with 4% para-
formaldehyde in phosphate-buffered saline (PFA/PBS) containing 20% sucrose, and their legs were dis-
sected. The specimens were fixed in 4% PFA/PBS containing 20% sucrose for 3 h, embedded in SCEM 
(Section-Lab, Japan), and frozen inn-hexane cooled with dry ice. Undecalcified frozen sections at a thick-
ness of 4 μ m were obtained according to Kawamoto’s film method using tungsten carbide blades, either 
TC-65 (Leica Microsystems, Japan) or SL-T35 (Section-Lab), and adhesive films (Section-Lab)67. After 
washing with ethanol and PBS, the sections were fixed in 4% PFA/PBS for 5 min. After blocking with 
3.2% skim milk/PBS, the sections were incubated at 4 °C with primary antibodies for overnight (more 
than 12 h), washed and then incubated with appropriate secondary antibodies conjugated with Alexa 
Fluor 568 (Life Technologies, USA). Nuclei were counterstained with 4′ ,6-diamidino-2-phenylindole 
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(DAPI) (Sigma). For immunostaining, MC3T3-E1 or HEK293T cells were seeded at 1 × 104 cells per 
well on the culture cover glass (MATSUNAMI, Japan), then the cells were transfected and/or treated 
with reagents for 24 h. Cells were fixed with 4% paraformaldehyde in PBS for 2 h at 4 °C, washed with 
PBS and incubated with primary antibodies with blocking buffer (3% BSA, 0.3% Triton X-100 in PBS) 
for overnight (more than 12 h). Cells were washed and then incubated with appropriate secondary anti-
bodies conjugated with Alexa Fluor 568 and/or FITC (Life Technologies) with blocking buffer for 2 h (in 
dark conditions). Cells were washed with PBS and the cover glass were mounted by fluorescent mounting 
medium (DAKO, USA).
Transfection and Co-Immunoprecipitation. 1 × 106 cells of HEK293T cells or MC3T3-E1 cells 
were seeded in 60 mm dish. Cells were transfected with each expression plasmid using ScreenFect A 
(WAKO) according to the manufacturer’s protocol. After 36 h of transfection, cells were lysed with 
300 μ l cell extraction lysis buffer (20 mM Tris–HCl (pH 7.4), 10 mM MgCl2, 2 mM EDTA, 10% glycerol, 
1% Triton X-100, 2.5 mM β -glycerophosphate,1 mM NaF, 1 mM DTT, and protease inhibitor cocktail 
(WAKO)) containing 500 mM NaCl for 30 minutes on ice (vortex for 10 seconds at maximum speed 
every 10 minutes), and then 700 μ l cell extraction lysis buffer without NaCl was added, followed by cell 
lysates were incubated for 30 minutes on ice (vortex for 10 seconds at maximum speed every 10 minutes). 
Cells were centrifuged at 4 °C, 15000 rpm for 20 minutes. Cell lysates were pre-cleared by 20 μ l rProtein 
G Agarose beads (Invitrogen) for 1 h at 4 °C with gentle rotating. Specific antibodies or IgG produced in 
rabbit or mouse were added together with 20 μ l rProtein G Agarose beads, respectively. Cell lysates were 
incubated at 4 °C for overnight. Then lysates were centrifuged at 500 g to recover the immune complex 
associated with the beads. The beads complexes were washed five times by gently resuspending in the 
cell extraction lysis buffer containing 150 mM NaCl, followed by centrifugation at 500 g. At last, 60 μ l 
2 × laemmli SDS-polyacrylamide gel electrophoresis sample buffer was added and incubated for 10 min-
utes. Total cell extracts, and immunoprecipitates were subjected to western blotting.
GST pulldown assay. Recombinant GST or OASIS N-terminus fused to GST (GST-OASIS-N) pro-
teins were prepared from E. coli BL21 strain transformed with the expressing vectors for GST only 
or OASIS N-terminus fused to GST. Recombinant GST/GST-OASIS-N proteins were purified using a 
glutathione Sepharose 4B beads (GE Healthcare, USA) with standard protocols. One hundred nano-
grams of GST/GST-OASIS-N proteins were incubated with the one milligram of whole cell lysates from 
MC3T3-E1 exposed to hypoxia within 1 ml cell extraction lysis buffer at 4 °C for overnight. The precip-
itated proteins were eluted by adding 2 × laemmli SDS sample buffer and detected by western blotting 
with anti-HIF-1α antibodies.
RNA interference. MC3T3-E1 cells were transfected by Lipofectamine RNAiMAX (Invitrogen) 
according to the manufacturer’s protocols. The transfected cells were incubated at 37 °C for 24 h, then 
cultured under the hypoxic conditions, and harvested for western blotting. The sequence for siRNA was 
as follows; (OASIS:5′ -GAAAUGAGCCAGUUUCUCAdTdT-3′ ).
Luciferase assay. HEK293T cells and MEFs plated onto 24-well plates were transfected with 0.2 μ g 
of a reporter plasmid carrying the firefly luciferase gene and 0.02 μ g of the reference plasmid pRL-SV40 
carrying the Renilla luciferase gene under the control of the SV40 enhancer and promoter with or with-
out 0.2 μ g of the OASIS-N and HIF-1α expression plasmids. After 24 h of transfection, cells were lysed 
in 200 μ l of Passive Lysis buffer (Promega, Germany). Firefly luciferase and Renilla luciferase activities 
in 20 μ l of cell lysates were measured using the Dual-Luciferase Reporter Assay System (Promega) and a 
luminometer (Promega). Relative activity was defined as the ratio of firefly luciferase activities to Renilla 
luciferase activities. Twenty microliter of cell lysates were used for western blotting.
Metatarsal angiogenesis assay. Metatarsals were removed from P0.5 WT and Oasis−/− mice, and 
dissected under a microscope. The isolated metatarsals were cultured in 24-well plates in 150 μ l of α -MEM 
supplemented with 10% (v/v) heat-inactivated fetal bovine serum for 72 h. Cultures were performed in 
sextuplet and each experiment was repeated at least twice. After 72 h, medium was replaced by 250 μ l 
fresh medium. Metatarsals were cultured for 12 days and medium was replaced every 3 days. At the end 
of the culture period, metatarsals were fixed in zinc macrodex formalin (ZnMF: 0.1 mM Tris-acetate, 
pH 4.5, 0.5% ZnCl2, 0.5% Zn acetate, 5% dextran, and 3.8% paraformaldehyde) fixative for 20 minutes at 
room temperature and subsequently stained for anti-CD31 as the immunostaining protocol.
Quantification of western blot and immunostaining. The quantification of western blotting was 
performed by Quantity one software. The quantification of immunostaining to measure the vessel’s area 
were performed by photoshop (Adobe) software using color threshold and measured the number of 
pixels as the vessel area.
Microarray analysis. Experimental sample RNAs (calvaria of wild-type and Oasis−/− mice at postnatal 
day 4) were isolated using RNeasy(Qiagen) and analysed using Mouse 385 K Array (MM8 60mer expr) 
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and MouseGenome 430 2.0 Array (Affymetrix) by NimbleGen Systems, Inc. and MiyazakiPrefectural 
Industrial Support Foundation, respectively.
Statistical analyses. Data are indicated as mean ± s.d. from at least three independent experiments 
for each experimental condition. Student’s t-test was performed to calculated P values. P < 0.05 was 
defined as significant.
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